Efficacy of the subcostal transversus abdominis plane block in laparoscopic cholecystectomy: Comparison with conventional port-site infiltration.
S Tolchard, R Davies, S Martindale
https://pubmed.ncbi.nlm.nih.gov/22869941/Actively Recruiting
Led by Helsinki University Central Hospital · Updated on 2026-10-05
850
Participants Needed
1
Research Sites
52 weeks
Total Duration
Researchers are conducting a randomized trial to compare two pain management methods during laparoscopic cholecystectomy LCC surgery, which treats conditions like gallstones, gallbladder inflammation, and gallbladder cancer. The study evaluates whether a combination of a laparoscopic ropivacaine transversus abdominis plane TAP block plus local trocar site infiltration called STALL is more effective than local wound infiltration alone for pain control. This trial aims to provide clearer evidence on the benefits of adding the TAP block to local anesthesia. Participants are assigned to one of several groups based on their surgery type daycare, inpatient, or emergency surgery. Each group either receives local trocar site ropivacaine infiltration alone or combined with the laparoscopically guided TAP block. Both procedures involve using ropivacaine to numb the surgical area, delivered during the laparoscopic procedure. The trial compares these methods to see which better controls pain after surgery. During the study, researchers monitor participants opioid use in the recovery area lasting about 1 to 4 hours as the primary outcome. Secondary measures include pain scores recorded for two days after surgery and total opioid use during hospital stays for inpatient or emergency cases. The study is double-blinded and randomized, ensuring unbiased comparison. Participants will be followed until the end of their recovery, and the trial completes by late 2027.
CONDITIONS
STALL vs Sole Local Wound Infiltration in Laparoscopic Cholecystectomy
R
Roman Kornõšev, MD
A
Alexey Schramko, MD, PhD, Doc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Helsinki University Central Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day of surgery
Participants receive either local trocar site ropivacaine infiltration alone or combined with a laparoscopically guided transversus abdominis plane block during laparoscopic cholecystectomy surgery.
Surgery day visit
Duration - Up to 2 days
Participants are monitored for pain and opioid use during recovery and hospital stay for up to 2 days after surgery.
Regular pain assessments every hour for 2 days
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
6
Have more questions? Get in touch with our team for quick support
S Tolchard, R Davies, S Martindale
https://pubmed.ncbi.nlm.nih.gov/22869941/Vilma Bumblyte, Suvi K Rasilainen, Anu Ehrlich...
https://pubmed.ncbi.nlm.nih.gov/34480217/Jaime Ruiz-Tovar, Alejandro Garcia, Carlos Ferrigni...
https://pubmed.ncbi.nlm.nih.gov/29980989/Rohan C Siriwardana, Sumudu K Kumarage, Bhagya M Gunathilake...
https://pubmed.ncbi.nlm.nih.gov/29943054/Sofronis Loizides, Kurinchi Selvan Gurusamy, Myura Nagendran...
https://pubmed.ncbi.nlm.nih.gov/24619479/Osman Nawazish Salaria, Murlikrishna Kannan, Bryan Kerner...
https://pubmed.ncbi.nlm.nih.gov/29214081/Ejas P Bava, Rashmi Ramachandran, Vimi Rewari...
https://pubmed.ncbi.nlm.nih.gov/27746552/Caius Mihai Breazu, Lidia Ciobanu, Adina Hadade...
https://pubmed.ncbi.nlm.nih.gov/28913472/Jaime Ortiz, James W Suliburk, Kenneth Wu...
https://pubmed.ncbi.nlm.nih.gov/22330261/Niranjan T Ravichandran, Sarath C Sistla, Pankaj Kundra...
https://pubmed.ncbi.nlm.nih.gov/28472015/Helsinki University Central Hospital
Lead Sponsor